BIOMEDICAL
Untitled Page
Natus acquires Fountain Valley's Alpine Biomed
The medical device manufacturer was bought by the San Carlos, Calif.-based company for $43.2 million.
By Susan BelknappPublished: September 16, 2009 10:26 AM
Fountain Valley-based Alpine Biomed Holdings Corp. was acquired by Natus Medical Inc., of San Carlos, in a deal that is expected to close today. Alpine Biomed is a leader in the development, manufacturing and sales of devices for the diagnosis of neurological disorders.
Natus provides equipment for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders and newborn care.
Alpine’s product line includes advanced electromyography systems for the diagnoses of peripheral nervous system dysfunctions as well as devices for routine EEG and long-term epilepsy monitoring. Water Street Healthcare Partners, a leading health care industry private equity firm, was the majority stockholder of Alpine Biomed.
Alpine Biomed has three neurology product divisions: Dantec, based in Copenhagen, Denmark; Stellate, located in Montreal, Canada; and the Alpine Biomed brand. The brands and products are sold in more than 50 countries.
Natus acquired all outstanding shares of Alpine Biomed capital stock for $43.2 million in cash, exclusive of direct costs of the acquisition. Alpine reported revenue of approximately $35 million in the twelve months ended June 30 through the neurology product divisions acquired by Natus.
NEXT PAGE >>
Related headlines
ARB inks $50 million deal
UC Irvine nets $2 million to become renewable energy lab
Natural gas-fueled trucks set to replace diesel vehicles at 2 Southern California ports
Aliso Viejo-based WePower reins in the wind
OC METRO, September issue: 'Huntington Beach's Green Expo'
|
||||
|
Fountain Valley-based Alpine Biomed Holdings Corp. was acquired by Natus Medical Inc., of San Carlos, in a deal that is expected to close today. Alpine Biomed is a leader in the development, manufacturing and sales of devices for the diagnosis of neurological disorders. Natus provides equipment for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders and newborn care. Alpine’s product line includes advanced electromyography systems for the diagnoses of peripheral nervous system dysfunctions as well as devices for routine EEG and long-term epilepsy monitoring. Water Street Healthcare Partners, a leading health care industry private equity firm, was the majority stockholder of Alpine Biomed. Alpine Biomed has three neurology product divisions: Dantec, based in Copenhagen, Denmark; Stellate, located in Montreal, Canada; and the Alpine Biomed brand. The brands and products are sold in more than 50 countries. Natus acquired all outstanding shares of Alpine Biomed capital stock for $43.2 million in cash, exclusive of direct costs of the acquisition. Alpine reported revenue of approximately $35 million in the twelve months ended June 30 through the neurology product divisions acquired by Natus. NEXT PAGE >> Related headlines ARB inks $50 million deal UC Irvine nets $2 million to become renewable energy lab Natural gas-fueled trucks set to replace diesel vehicles at 2 Southern California ports Aliso Viejo-based WePower reins in the wind OC METRO, September issue: 'Huntington Beach's Green Expo' |
||||
